Chengdu SciMount Pharmatech Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2015-05-07
- Employees
- -
- Market Cap
- -
- Website
- http://www.xilinglab.com
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Chengdu SciMount Pharmatech Co., Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT05029518
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
A Phase 1 Study of SMP-100 in Normal Healthy Volunteers
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Chengdu SciMount Pharmatech Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT04296799
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
© Copyright 2025. All Rights Reserved by MedPath